Since adiponectin and leptin have been reported to have opposing activities on breast cancer progression, we also assessed whether their ratio might provide an index of intervention effectiveness but found that the variability of the ratio makes it problematic in this regard. This evidence concerns the gene LEP and breast carcinoma.